Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Genetic Signatures and Microba in Merger Talks

PRIVATEAug 26, 2026about 4 hours ago

Acquiring Company

Genetic Signatures Limited

Acquired Company

Microba Life Sciences Limited

SydneyBiotechnologyHealth CareBiotechnologyHealth CareMedicalTherapeutics

Description

Genetic Signatures is in discussions with Microba Life Sciences regarding a potential merger to create a broader diagnostics group. This combination aims to merge their strengths in infectious disease diagnostics and microbiome testing. Both companies see opportunities for operational synergies and expanded market access. Preliminary discussions have begun but no binding agreement has been reached.

Company Information

Company

Genetic Signatures Limited

Location

Sydney, New South Wales, Australia

About

Genetic Signatures specializes in infectious disease detection through its proprietary 3base® platform technology. It offers EasyScreen™ PCR-based products for high-volume screening in hospital and pathology labs. The company aims to create efficient diagnostics solutions. Genetic Signatures is listed on the Australian Securities Exchange (ASX).

Don't miss Genetic Signatures Limited's next move

Get an email the moment Genetic Signatures Limited makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Genetic Signatures Limited's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Microba Life Sciences Limited?

Microba Life Sciences Limited was acquired by Genetic Signatures Limited, based in Sydney. The deal was reported on August 26, 2026. Genetic Signatures specializes in infectious disease detection through its proprietary 3base® platform technology. It offers EasyScreen™ PCR-based products for high-volume screening in hospital and pathology labs. Genetic Signatures Limited is privately held and operates in Biotechnology.

When did Genetic Signatures Limited acquire Microba Life Sciences Limited?

Genetic Signatures Limited's acquisition of Microba Life Sciences Limited was reported on August 26, 2026. Genetic Signatures is in discussions with Microba Life Sciences regarding a potential merger to create a broader diagnostics group. This combination aims to merge their strengths in infectious disease diagnostics and microbiome testing. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Microba Life Sciences Limited do?

Microba Life Sciences is a precision microbiome company driven to improve human health. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.